Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer
Yan Liu,1,2,* Meng Gao,3,* Juan An,2,* Xin Wang,4 Yan Jia,4 Junfeng Xu,4 Jihai Zhu,5 Jiantao Cui,1 Wenmei Li,1 Rui Xing,1 Li Song,6 Kejia Liu,6 Yuqi He,4 Jianqiu Sheng,4 Shengmei Qi,3 Yuanming Pan,1,4 Youyong Lu1 1Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational R...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-08-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/dysregulation-of-mir-30a-3pgastrin-enhances-tumor-growth-and-invasion--peer-reviewed-article-OTT |
id |
doaj-19b886f2bb4846f79806d5b6e686320f |
---|---|
record_format |
Article |
spelling |
doaj-19b886f2bb4846f79806d5b6e686320f2020-11-25T03:42:42ZengDove Medical PressOncoTargets and Therapy1178-69302020-08-01Volume 138475849356580Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric CancerLiu YGao MAn JWang XJia YXu JZhu JCui JLi WXing RSong LLiu KHe YSheng JQi SPan YLu YYan Liu,1,2,* Meng Gao,3,* Juan An,2,* Xin Wang,4 Yan Jia,4 Junfeng Xu,4 Jihai Zhu,5 Jiantao Cui,1 Wenmei Li,1 Rui Xing,1 Li Song,6 Kejia Liu,6 Yuqi He,4 Jianqiu Sheng,4 Shengmei Qi,3 Yuanming Pan,1,4 Youyong Lu1 1Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing Cancer Hospital/Institute, School of Oncology, Peking University, Beijing, Haidian District 100142, People’s Republic of China; 2Department of Basic Medical Sciences, Medical College of Qinghai University, Xining City, Qinghai 810001, People’s Republic of China; 3OnkoRx Ltd. Beijing, Beijing, Haidian District 100085, People’s Republic of China; 4Department of Gastroenterology, The 7th Medical Center of Chinese PLA General Hospital, Beijing, Dongcheng District 100700, People’s Republic of China; 5Department of Cardiothoracic Surgery, The Affiliated Hospital of Qinghai University, Xining City, Qinghai 810001, People’s Republic of China; 6Yidu Cloud (Beijing) Technology Co., Ltd. 8F, Health Work, Beijing, Haidian District 100083, People’s Republic of China*These authors contributed equally to this workCorrespondence: Youyong Lu, MD, Ph.D.Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing Cancer Hospital/Institute, School of Oncology, Peking University, Beijing 100142, People’s Republic of ChinaTel +86-10-88196765Fax +86-10-88122437Email youyonglu@hsc.pku.edu.cnBackground: Gastrin (GAST) is a well-known hormone regulating gastric biofunctions in the secretion of acid and maintaining its structural integrity. Furthermore, the dysregulation of GAST is also involved in the development of various forms of cancer. However, there are some limitations for illustrating the cellular regulation of GAST and its regulatory mechanisms in gastric malignant transformation and the potential epigenetic regulators systematically.Methods: We explored the role of GAST expression in gastric cancer (GC) and normal tissues with the clinical features and investigated the potential relationship between GAST and STAT3/MMP11 pathway by gain or loss of function analyses. Besides, based on our microRNA/mRNA expression profiles, miR-30a-3p was the potential epigenetic regulator and additional experiments were performed to identify the hypothesis.Results: Elevated GAST expression was frequently detected in GC and was associated with worse outcomes (p< 0.001). And we firstly demonstrated that GAST was negatively regulated by miR-30a-3p. Moreover, GAST induced GC cell proliferation, migration and invasion mediating STAT3/MMP11 pathway in this study.Conclusion: MiR-30a-3p was the promising suppressor gene through negatively regulating the expression of GAST, and dysregulation of GAST was a prognostic signature associated cell proliferation and metastasis through STAT3/MMP11 pathway in GC.Keywords: gastrin, proliferation, invasion, miR-30a-3p, STAT3/MMP11 pathway, gastric cancerhttps://www.dovepress.com/dysregulation-of-mir-30a-3pgastrin-enhances-tumor-growth-and-invasion--peer-reviewed-article-OTTgastrinproliferationinvasionmir-30a-3pstat3/mmp11 pathwaygastric cancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Liu Y Gao M An J Wang X Jia Y Xu J Zhu J Cui J Li W Xing R Song L Liu K He Y Sheng J Qi S Pan Y Lu Y |
spellingShingle |
Liu Y Gao M An J Wang X Jia Y Xu J Zhu J Cui J Li W Xing R Song L Liu K He Y Sheng J Qi S Pan Y Lu Y Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer OncoTargets and Therapy gastrin proliferation invasion mir-30a-3p stat3/mmp11 pathway gastric cancer |
author_facet |
Liu Y Gao M An J Wang X Jia Y Xu J Zhu J Cui J Li W Xing R Song L Liu K He Y Sheng J Qi S Pan Y Lu Y |
author_sort |
Liu Y |
title |
Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer |
title_short |
Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer |
title_full |
Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer |
title_fullStr |
Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer |
title_full_unstemmed |
Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer |
title_sort |
dysregulation of mir-30a-3p/gastrin enhances tumor growth and invasion throughstat3/mmp11 pathway in gastric cancer |
publisher |
Dove Medical Press |
series |
OncoTargets and Therapy |
issn |
1178-6930 |
publishDate |
2020-08-01 |
description |
Yan Liu,1,2,* Meng Gao,3,* Juan An,2,* Xin Wang,4 Yan Jia,4 Junfeng Xu,4 Jihai Zhu,5 Jiantao Cui,1 Wenmei Li,1 Rui Xing,1 Li Song,6 Kejia Liu,6 Yuqi He,4 Jianqiu Sheng,4 Shengmei Qi,3 Yuanming Pan,1,4 Youyong Lu1 1Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing Cancer Hospital/Institute, School of Oncology, Peking University, Beijing, Haidian District 100142, People’s Republic of China; 2Department of Basic Medical Sciences, Medical College of Qinghai University, Xining City, Qinghai 810001, People’s Republic of China; 3OnkoRx Ltd. Beijing, Beijing, Haidian District 100085, People’s Republic of China; 4Department of Gastroenterology, The 7th Medical Center of Chinese PLA General Hospital, Beijing, Dongcheng District 100700, People’s Republic of China; 5Department of Cardiothoracic Surgery, The Affiliated Hospital of Qinghai University, Xining City, Qinghai 810001, People’s Republic of China; 6Yidu Cloud (Beijing) Technology Co., Ltd. 8F, Health Work, Beijing, Haidian District 100083, People’s Republic of China*These authors contributed equally to this workCorrespondence: Youyong Lu, MD, Ph.D.Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing Cancer Hospital/Institute, School of Oncology, Peking University, Beijing 100142, People’s Republic of ChinaTel +86-10-88196765Fax +86-10-88122437Email youyonglu@hsc.pku.edu.cnBackground: Gastrin (GAST) is a well-known hormone regulating gastric biofunctions in the secretion of acid and maintaining its structural integrity. Furthermore, the dysregulation of GAST is also involved in the development of various forms of cancer. However, there are some limitations for illustrating the cellular regulation of GAST and its regulatory mechanisms in gastric malignant transformation and the potential epigenetic regulators systematically.Methods: We explored the role of GAST expression in gastric cancer (GC) and normal tissues with the clinical features and investigated the potential relationship between GAST and STAT3/MMP11 pathway by gain or loss of function analyses. Besides, based on our microRNA/mRNA expression profiles, miR-30a-3p was the potential epigenetic regulator and additional experiments were performed to identify the hypothesis.Results: Elevated GAST expression was frequently detected in GC and was associated with worse outcomes (p< 0.001). And we firstly demonstrated that GAST was negatively regulated by miR-30a-3p. Moreover, GAST induced GC cell proliferation, migration and invasion mediating STAT3/MMP11 pathway in this study.Conclusion: MiR-30a-3p was the promising suppressor gene through negatively regulating the expression of GAST, and dysregulation of GAST was a prognostic signature associated cell proliferation and metastasis through STAT3/MMP11 pathway in GC.Keywords: gastrin, proliferation, invasion, miR-30a-3p, STAT3/MMP11 pathway, gastric cancer |
topic |
gastrin proliferation invasion mir-30a-3p stat3/mmp11 pathway gastric cancer |
url |
https://www.dovepress.com/dysregulation-of-mir-30a-3pgastrin-enhances-tumor-growth-and-invasion--peer-reviewed-article-OTT |
work_keys_str_mv |
AT liuy dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT gaom dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT anj dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT wangx dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT jiay dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT xuj dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT zhuj dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT cuij dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT liw dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT xingr dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT songl dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT liuk dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT hey dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT shengj dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT qis dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT pany dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer AT luy dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer |
_version_ |
1724524109146095616 |